進階篩選

Technical category
技術研發單位
  • 共有:43筆資料
  • 顯示:
  • 筆商品
    • AI_Variant Prioritizer

      Precision Health Ecosystem FutureTech AI_Variant Prioritizer

      The interpretation of next generation sequencing is a big challenge. In order to improve the molecular diagnosis of the patient, we developed the AI_Variant prioritizer, a machine learning based variant prioterization system that can help to prioritize candidate variants for human disease. This module highlighted the possible disease causing variants to help clinician to increase the disease diagnostic yield and decrease the load of manpower.
    • Intelligent image-guiding needle puncture

      Precision Health Ecosystem FutureTech Intelligent image-guiding needle puncture

      Optical coherence tomography using an optical probe with a diameter of 0.9 mm, combined with the 14-18 gauge needle, is used for clinical needle puncture. Using the real-time image obtained from the tip of the needle in the tissue, the needle position can be identified. Combined with artificial intelligence can achieve objective, accurate and automatic identification of the tissue, which has been successfully verified in anesthesia and laparoscopic surgery.
    • The establishment of National Biobank Consortium of Taiwan (NBCT)

      Precision Health Ecosystem FutureTech The establishment of National Biobank Consortium of Taiwan (NBCT)

      This project will establish a National biobank consortium of Taiwan through the fund support from the government. The National Health Research Institutes will establish a Central Office for the collaboration works, which includes collecting the number of samples of the human biological database in each biobank that agreed to join the Consortium. All Alliance need to follow the same SOP for the collection process and the quality of the biosample. Adequate and consistent clinical data will also be established under the Information Security Management Treaty. Since the contents of the biobanks from different institute are quite different, we will be able to quickly establish a large and comprehensive biobank network.In line with the need of biotechnology and pharmaceutical industries.
    • Low-dose nanoscale biomimetic cell structure – Next-generation platform technology for advanced precision immunotherapy

      Precision Health Ecosystem FutureTech Low-dose nanoscale biomimetic cell structure – Next-generation platform technology for advanced precision immunotherapy

      We developed a biomimetic triple-antibody-immobilized magnetic fucoidan nanomedicine as a multifunctional artificial antigen presenting cell, which possessed the ability to not only inhibit immune checkpoint but activate tumor infiltrated T cells. of Bridging sites with tunable density on the nanoplatform was designed, allowing the antibodies to be well-distributed on the surface for mimicking immune cells. In contrast to the complex cell expansion process using microbeads in adaptive cell therapy, the nanoplatform can be i.v. administrated to cut the course of therapy from several weeks to days. With the development of the platform technology, an artificial immune system family can be built to pave the way for personalized immunotherapy.
    • First-in-class anti-diabetic drug, PS1

      Precision Health Ecosystem FutureTech First-in-class anti-diabetic drug, PS1

      Diabetes is now still an incurable disease. Beta cell failure is one of common causes. No drugs for this failure have been developed. This invention is to developapply PS1 to treatreverse diabetes. PS1 is a first-in-class small-molecule drug, which targets beta cells by improving their survivalfunction. As a result, PS1 can treatreverse diabetes. The anti-diabetic mechanism of
    • Precision blood test for detection of breast cancer

      Precision Health Ecosystem FutureTech Precision blood test for detection of breast cancer

      EPICAn is a novel technique that uses liquid biopsy for epigenetic analysis. Using methylation-specific PCR method to analyze specific gene methylation of cell-free DNA in plasma for early detection of breast cancer. The advantages of this technology are 1. High accuracy 2. Low false positive rate 3. Low-invasive 4. less limitation 5. Available for routine continuous detection 6. Monitoring cancer changes 7. Aided diagnosis 8. Automated process 9. Easy-to-operate 10. Rapid analysis. It is expected that EPICAn technique can increase the accuracy of early detection of breast cancer and aid clinicians' diagnosis.
    • METHOD FOR LOWERING CANNIBALISM RATE IN FISH AND COMPOSITION

      Precision Health Ecosystem FutureTech METHOD FOR LOWERING CANNIBALISM RATE IN FISH AND COMPOSITION

      This technique used algae-a natural raw ingredient as novel functional aquafeed additives, as replacement for fish meal in nutrition sources, a fish oil replacement in the feed, an algae strain contains unsaturated fatty acid can change level of serotoninblood cortisol in fish brain, decrease their cannibalism rate. This technique can reduce feed production costincrease harvesting rate.
    • Switch on a coming era to preservation of agricultural produce

      Precision Health Ecosystem FutureTech Switch on a coming era to preservation of agricultural produce

      To develop a potential preservative from microorganisms, Aureobasidium pullulans was the positive candidates. In a laboratory scale, we introduced the Aureobasidium pullulans broth into a practical delivery chain to simulate the commercial process. For disease severitybanana degreening, the results indicated we could obtain a better consistencylonger storage time for exports as well.
    • Consumables-free, remote,rapid optical detection of plant pathogensDr. Lan

      Precision Health Ecosystem FutureTech Consumables-free, remote,rapid optical detection of plant pathogensDr. Lan

      Based on the optical fluorescence of the plant, the technology distinguishes the difference of the main protein infected by virus from the normal ones with the feature light. The main difference of this technology is to omit the complicatedbiochemical-material- consumption procedures. With the establishment of big data, the artificial intelligence algorithm identifies whether the implant is.
    • A Manual CentrifugePaper Devices for Point-of-Care Diagnosis

      Precision Health Ecosystem FutureTech A Manual CentrifugePaper Devices for Point-of-Care Diagnosis

      Here, we introduce an electricity-free centrifuge platform based on a manual centrifuge. The provided centrifugal force is sufficient to produce a plasma purity of 99 separated in as little as 2−3 min. We then performed an immunoassay on a paper devicethe results were observed by a portable reader. As a result, the detection limit of the C-Reactive Protein is 1 ng/mL, with a total turnaround time of 7 min.
本網站使用您的Cookie於優化網站。繼續瀏覽網站即表示您同意本公司隱私權政策,您可至隱私權政策了解詳細資訊。